Cargando…

COVID-19, quarantine, and atopic dermatitis

Detalles Bibliográficos
Autores principales:	Patruno, Cataldo, Nisticò, Steven Paul, Fabbrocini, Gabriella, Napolitano, Maddalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Letter to Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236680/ https://www.ncbi.nlm.nih.gov/pubmed/32447099 http://dx.doi.org/10.1016/j.mehy.2020.109852

Ejemplares similares

Upadacitinib improved alopecia areata in a patient with atopic dermatitis: A case report
por: Cantelli, Mariateresa, et al.
Publicado: (2022)

Treatment of Atopic Dermatitis with Biologic Drugs
por: Fabbrocini, Gabriella, et al.
Publicado: (2018)

Dupilumab for the treatment of atopic dermatitis in transplant patients: Two case reports and literature review
por: Napolitano, Maddalena, et al.
Publicado: (2022)

The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis
por: Napolitano, Maddalena, et al.
Publicado: (2023)

Children atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implication
por: Napolitano, Maddalena, et al.
Publicado: (2022)

Profile of Baricitinib and Its Potential in the Treatment of Moderate to Severe Atopic Dermatitis: A Short Review on the Emerging Clinical Evidence
por: Napolitano, Maddalena, et al.
Publicado: (2020)

The Efficacy and Safety of Abrocitinib as a Treatment Option for Atopic Dermatitis: A Short Report of the Clinical Data
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Effect of Dupilumab on Sexual Desire in Adult Patients with Moderate to Severe Atopic Dermatitis
por: Napolitano, Maddalena, et al.
Publicado: (2022)

Reply: Potential role of Janus kinase inhibitors in COVID-19
por: Napolitano, Maddalena, et al.
Publicado: (2020)

Delayed urticaria after the third dose of mRNA COVID19 vaccine: A case series
por: Bianchi, Leonardo, et al.
Publicado: (2022)

Contact allergy in children with and without atopic dermatitis: An Italian multicentre study
por: Bonamonte, Domenico, et al.
Publicado: (2022)

Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
por: Megna, Matteo, et al.
Publicado: (2022)

Systemic Treatment of Adult Atopic Dermatitis: A Review
por: Megna, Matteo, et al.
Publicado: (2016)

Prevalence of Chronic Inducible Urticaria in Elderly Patients
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Skin rashes after SARS‐CoV‐2 vaccine: which relationship, if any?
por: Patruno, Cataldo, et al.
Publicado: (2021)

May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?
por: Marasca, Claudio, et al.
Publicado: (2020)

Urticaria relapse after mRNA COVID‐19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single‐center experience
por: Picone, Vincenzo, et al.
Publicado: (2022)

Vitiligo during dupilumab therapy
por: Picone, Vincenzo, et al.
Publicado: (2023)

Erythema Multiforme and COVID-19: What Do We Know?
por: Bennardo, Luigi, et al.
Publicado: (2021)

Role of Aryl Hydrocarbon Receptor Activation in Inflammatory Chronic Skin Diseases
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Atopic Dermatitis Is Associated with Preeclampsia and Endometriosis
por: Barbieri, John S., et al.
Publicado: (2022)

Efficacy and Safety of Dupilumab in Clinical Practice: One Year of Experience on 165 Adult Patients from a Tertiary Referral Centre
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Refractory Atopic Dermatitis in Childhood: Improvement with Methotrexate?
por: Park, Young Woon, et al.
Publicado: (2013)

Neutrophilic Dermatosis in Pregnancy: An Uncommon Course
por: Villani, Alessia, et al.
Publicado: (2018)

Use of Humidifiers with Children Suffering from Atopic Dermatitis
por: Kim, Eun-Hye, et al.
Publicado: (2012)

The Clinical Efficacy of Azathioprine in Korean Patients with Atopic Dermatitis
por: Lee, Hemin, et al.
Publicado: (2015)

Letter to The Editor on ‘Evaluation of antimicrobial textiles for atopic dermatitis’
por: Kopera, D.
Publicado: (2019)

COVID-19 sends STEMI to quarantine!?
por: Abdi, Seifollah, et al.
Publicado: (2020)

No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis
por: Zhou, Boyang, et al.
Publicado: (2023)

Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment
por: Napolitano, Maddalena, et al.
Publicado: (2017)

Home quarantine or centralized quarantine, which is more conducive to fighting COVID-19 pandemic?
por: Zhu, Ya, et al.
Publicado: (2020)

Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications
por: Marasca, Claudio, et al.
Publicado: (2022)

Use of Emollients in Atopic Dermatitis: A Questionnaire Survey Study
por: Lee, Ji Hyun, et al.
Publicado: (2014)

Loose anagen hair syndrome: Is there any association with atopic dermatitis?
por: Dey, Vivek Kumar, et al.
Publicado: (2016)

Prevalence of excessive daytime sleepiness among patients with atopic dermatitis
por: Halioua, Bruno, et al.
Publicado: (2023)

Potential threats of COVID-19 on quarantined families
por: Ansari, M., et al.
Publicado: (2020)

Country Quarantine During COVID-19: Critical or Not?
por: Samieefar, Noosha, et al.
Publicado: (2020)

The Role of Photoprotection in Optimizing the Treatment of Atopic Dermatitis
por: Piquero-Casals, Jaime, et al.
Publicado: (2021)

Erythema Migrans-like COVID Vaccine Arm: A Literature Review
por: Fasano, Gaia, et al.
Publicado: (2022)

Severe Refractory Atopic Dermatitis in an Adolescent Patient Successfully Treated with Ustekinumab
por: Agusti-Mejias, Anna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c0u60a6bsapjbggbjnm7mn0kc3